EP
GILD icon

Eudaimonia Partners’s Gilead Sciences GILD Stock Holding History

Eudaimonia Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,053
Closed -$229K – 286
2023
Q3 		$229K Buy
3,053
+183
+6% +$14.1K 0.06% 280
2023
Q2 		$221K Sell
2,870
-263
-8% -$21K 0.05% 305
2023
Q1 		$260K Sell
3,133
-829
-21% -$68.7K 0.06% 279
2022
Q4 		$340K Sell
3,962
-248
-6% -$19.6K 0.08% 235
2022
Q3 		$260K Sell
4,210
-313
-7% -$19.7K 0.07% 262
2022
Q2 		$280K Buy
4,523
+1,103
+32% +$68.3K 0.05% 304
2022
Q1 		$203K Buy
+3,420
New +$219K 0.03% 382
2021
Q2 		– Sell
-3,162
Closed -$204K – 750
2021
Q1 		$204K Sell
3,162
-894
-22% -$57.6K 0.04% 331
2020
Q4 		$236K Sell
4,056
-4,560
-53% -$275K 0.05% 280
2020
Q3 		$544K Buy
8,616
+4,588
+114% +$318K 0.14% 159
2020
Q2 		$310K Sell
4,028
-761
-16% -$58.3K 0.12% 181
2020
Q1 		$358K Buy
4,789
+1,771
+59% +$122K 0.16% 155
2019
Q4 		$196K Buy
+3,018
New +$197K 0.08% 239

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eudaimonia Partners's GILD Position: Q4 2023 in Review

Eudaimonia Partners sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 3,053 shares — an estimated $229K sold.

Eudaimonia Partners first reported a position in GILD in Q4 2019 and held it in 13 quarters. The position peaked at $544K in Q3 2020. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • Eudaimonia Partners reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
  • Eudaimonia Partners sold 3,053 Gilead Sciences shares in Q4 2023, an estimated $229K.
  • Eudaimonia Partners first reported a position in Gilead Sciences in Q4 2019 and held it in 13 quarters.
  • Eudaimonia Partners's Gilead Sciences position peaked at $544K in Q3 2020.
  • 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Eudaimonia Partners's 13F filing for Q4 2023, filed 8 Feb 2024.